Organization
United States Food and Drug Administration
Top stories
Latest reports
- FDA Approves Livsayis™ (cemdisiran) for Adults Living with Generalized Myasthenia Gravis
GlobeNewswireUSStory
Add to CRM - Cipla’s US manufacturing facility gets ‘No Action Indicated’ status from FDA
Business LineINStory
Add to CRM
- The FDA approves first treatment for Sanfilippo syndrome, offering hope to families
WCVB-TVUS2 outlets
Add to CRM
- Roche breast cancer pill cleared by FDA
biopharmadive.comStory
Add to CRM